Primary Epstein–Barr virus infection with neurological complications

Abstract Several case studies have reported on neurological complications caused by a primary Epstein–Barr virus (EBV) infection. We aimed to investigate the viral loads and the clinical and inflammatory characteristics of this disease entity. We evaluated all 84 cases in which the EBV polymerase chain reaction test (PCR) was requested on cerebrospinal fluid (CSF) for the period 2003–2008. Fourteen patients with proven neuroborreliosis served as the control group. Nine patients were diagnosed with a primary EBV infection and neurological symptoms (median age 36 y; 4 male). Viral DNA copies in CSF were detected by PCR in 7 of 9 patients. The presenting symptoms were meningeal signs, epileptic insults, polyradiculomyelitis, polyradiculitis, and/or sudden cognitive disorders. All EBV cases had a pleocytosis with significantly increased mononuclear leukocytes as compared to the neuroborreliosis group (median 99% interquartile range (96–100%) versus 90% (86–97%). In cases with a primary EBV infection, viral loads ranged from 43 to 3202 copies/ml in CSF and from 61 to 15,595 copies/ml in serum. Seventy-eight percent of the cases had a positive PCR on CSF. This study provides criteria for diagnosing neurological disease during primary EBV infection. Primary EBV infections in immune competent persons can cause a broad range of neurological symptoms, with lymphocytic and monocytic inflammation both in blood and CSF.

[1]  E. Iannitto,et al.  Angioimmunoblastic T-cell lymphoma. , 2008, Critical reviews in oncology/hematology.

[2]  A. Moormann,et al.  Immune escape by Epstein-Barr virus associated malignancies. , 2008, Seminars in cancer biology.

[3]  L. Griffiths,et al.  Immunodeficiency-associated lymphomas. , 2008, Blood reviews.

[4]  B. Ibach,et al.  Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms , 2008, Infection.

[5]  R. Hamoudi,et al.  Angioimmunoblastic T‐cell lymphoma: histological progression associates with EBV and HHV6B viral load , 2007, British journal of haematology.

[6]  H. Myrmel,et al.  Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  M. Odenthal,et al.  The role of Epstein-Barr virus in acute and chronic hepatitis. , 2006, Journal of hepatology.

[8]  K. Tyler,et al.  Dual infections of the central nervous system with Epstein-Barr virus. , 2005, The Journal of infectious diseases.

[9]  M. Gulley,et al.  Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[10]  T. Imaizumi,et al.  Epstein-Barr virus infections of the central nervous system. , 2003, Internal medicine.

[11]  K. Tyler,et al.  Quantitative CSF PCR in Epstein–Barr virus infections of the central nervous system , 2002, Annals of neurology.

[12]  A. Majid,et al.  Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. , 2002, Brain : a journal of neurology.

[13]  G. Tetrault Infections in heterophile-negative patients. , 2001, Archives of pathology & laboratory medicine.

[14]  T. Tjade,et al.  Evaluation of 12 Commercial Tests for Detection of Epstein-Barr Virus-Specific and Heterophile Antibodies , 2000, Clinical Diagnostic Laboratory Immunology.

[15]  L. Hagberg,et al.  Herpesvirus DNA detection in cerebral spinal fluid: differences in clinical presentation between alpha-, beta-, and gamma-herpesviruses. , 2000, Scandinavian journal of infectious diseases.

[16]  G. Guaraldi,et al.  Epstein-barr virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus infection and central nervous system disorders. , 1999, The new microbiologica.

[17]  P. Auwaerter Infectious mononucleosis in middle age. , 1999, JAMA.

[18]  K. Takada [Virus-associated malignancies]. , 1999, Ryoikibetsu shokogun shirizu.

[19]  C. Marra,et al.  Infections of the central nervous system. , 1991, Advances in internal medicine.

[20]  L. Hagberg,et al.  Acute viral encephalitis in adults--a prospective study. , 1998, Scandinavian journal of infectious diseases.

[21]  V. Schuster,et al.  Activated T lymphocytes in the cerebrospinal fluid of a patient with Epstein-Barr virus-associated meningoencephalitis. , 1996, The Pediatric infectious disease journal.

[22]  K. Hirai,et al.  Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases , 1995, Journal of clinical microbiology.

[23]  A. Lazzarin,et al.  Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system , 1993, The Lancet.

[24]  H. Reiber,et al.  Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. , 1991, Clinical chemistry.

[25]  A. Evans Infectious mononucleosis and other mono-like syndromes. , 1972, The New England journal of medicine.